If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you ...
RedChip Companies will air interviews with Connect Biopharma Holdings Limited (Nasdaq:CNTB) and Bimergen Energy Corp.
News-Medical.Net on MSN
Exploring m6A RNA modification as a therapeutic target in cardiovascular disorders
Emerging research highlights the transformative potential of m6A RNA modification in the diagnosis and treatment of ...
For that, there’s a room at the far end of her lab — the bioprinting room — where she works with a team to create 3D printed vessels that the cells can be printed into. Bioprinting allows Kaw to study ...
Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...
An inquest heard an 82-year-old Aikton farmer died in hospital after being trampled by a cow while working on his farm.
Merck & Co., Inc. acquires Cidara Therapeutics, Inc. for $9.2bn, boosting its pipeline with CD388's strong flu data. Click ...
Pre-NDA meeting with FDA to discuss brilaroxazine's path to approval for schizophrenia planned in Q4 2025 - - Potential NDA submission for schizophrenia indication targeted for Q2 2026 - - European ...
Vallerie McLaughlin, MD, the Kim A. Eagle M.D. Endowed Professor of Cardiovascular Medicine and professor of internal medicine at the University of Michigan Medical School, highlighted the need for ...
Company preparing to initiate comprehensive Phase 3 program for chronic cough in patients with idiopathic pulmonary fibrosis in first half of 2026 Company ended ...
World Pneumonia Day highlights the rising threat of pneumonia, particularly in young children and the elderly. This ...
It feels like there’s always something new popping up in medicine, and cardiac ablation is no different. Boston Scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results